November 24th, 2014
Selections from Richard Lehman’s Literature Review: November 24th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the PROTECT-AF trial, the association of inpatient vs. outpatient onset of STEMI with treatment and clinical outcomes, and more.
June 9th, 2014
Selections from Richard Lehman’s Literature Review: June 9th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the CORONARY trial, the association of azithromycin with mortality and CV events among older patients hospitalized with pneumonia, and more.
May 8th, 2014
Selections from Richard Lehman’s Literature Review: May 8th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include darapladib for preventing ischemic events in stable CHD, the DAMASCENE analysis, a review of John Brush’s new book, and more.
January 22nd, 2014
SERIES: Making Sense of the New Prevention Guidelines — The View from Clinical Practice
Harlan M. Krumholz, MD, SM
A series of clinical vignettes involving decisions affected by the recently published prevention guidelines (JNC 8, ACC/AHA, ESC)
December 23rd, 2013
Statins: Targeting Risk, but Risking Diabetes?
Emma Morton-Eggleston, MD, MPH and Richard Lehman, BM, BCh, MRCGP
Emma Morton-Eggleston and Richard Lehman share their correspondence with us, in which they debate whether it’s worth using statins to target CV risk if they might increase other risks, such as diabetes.
November 20th, 2013
AHA.13: Good until the End
Seth Shay Martin, MD
On the last afternoon at AHA.13, a poster on an experimental preventive treatment catches the eye of a cardiology Fellow .
September 3rd, 2013
A Transatlantic Taste
Amanda Ruth Vest, MBBS
A fellow wonders about worldwide differences in clinical and research approaches in cardiology, as she attends a session on a controversial area that sits uncomfortably alongside the weight-loss message central to American efforts to improve cardiovascular health.
April 5th, 2013
Cardio-Oncology: Who Needs It?
John Ryan, MD
Our panel sketches out the scope of this growing discipline.
November 12th, 2012
Selections from Richard Lehman’s Literature Review: November 12th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include multivitamins for the prevention of CVD in men, the TRILOGY ACS trial, statin use and reduced cancer mortality, and more.
November 16th, 2011
Evacetrapib – The New Wonder Drug?
Amit Shah, MD, MSCR
Impressive safety and efficacy data on evacetrapib—but it’s too early give odds on whether it’s a true wonder drug or a nightmare like its fellow CETP inhibitor, torceptrapib
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?